| scholarly article | Q13442814 |
| P2093 | author name string | Thompson JM | |
| Tomlinson JE | |||
| Thomson NC | |||
| Wood SF | |||
| Chaudhuri R | |||
| McMahon AD | |||
| P2860 | cites work | Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 |
| Morbidity from asthma in relation to regular treatment: a community based study | Q33545064 | ||
| Fortnightly review: modern drug treatment of chronic asthma | Q33793696 | ||
| A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force | Q34090755 | ||
| Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma | Q35535023 | ||
| Respiratory medications and risk of asthma death | Q35535345 | ||
| Asthma and cigarette smoking. | Q35933941 | ||
| Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma | Q39241908 | ||
| Peak flow rate records in surveys: reproducibility of observers' reports | Q41121733 | ||
| Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma | Q44534206 | ||
| Asthma phenotypes according to the timing of smoking onset in young adults | Q47966285 | ||
| Cigarette smoking among asthmatic adults presenting to 64 emergency departments. | Q51674213 | ||
| Development and validation of a questionnaire to measure asthma control. | Q53341478 | ||
| Familial Risk of Lung Carcinoma in the Icelandic Population | Q57267217 | ||
| A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma | Q57956064 | ||
| Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use? | Q61892534 | ||
| Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking | Q71078847 | ||
| Which index of peak expiratory flow is most useful in the management of stable asthma? | Q72204963 | ||
| Cigarette smoking and asthma symptom severity among adult asthmatics | Q77817095 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 282-287 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma | |
| P478 | volume | 60 |
| Q36539160 | 1-year prospective real life monitoring of asthma control and quality of life in Italy |
| Q34474468 | A call for action: Comparative effectiveness research in asthma |
| Q38930984 | Addressing corticosteroid insensitivity in adults with asthma |
| Q51683649 | Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking. |
| Q64245837 | Asthma Across Age: Insights From Primary Care |
| Q38579892 | Asthma risk factors |
| Q26785749 | Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge |
| Q91686040 | Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial |
| Q46055749 | Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma |
| Q30831813 | Can asthma control be improved by understanding the patient's perspective? |
| Q37733518 | Challenges of treating asthma in people who smoke |
| Q50928110 | Characteristics and Prognosis of Never-Smokers and Smokers with Asthma in the Copenhagen General Population Study. A Prospective Cohort Study. |
| Q35216003 | Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study |
| Q45829435 | Complementing the randomized controlled trial evidence base. Evolution not revolution. |
| Q98735558 | Contribution of IL-17 in Steroid Hyporesponsiveness in Obese Asthmatics Through Dysregulation of Glucocorticoid Receptors α and β |
| Q37698922 | Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day |
| Q42752988 | Coughs and wheezes spread diseases: but what about the environment? |
| Q37670489 | Current approaches to pharmacotherapy for smoking cessation |
| Q38026991 | Do small airway abnormalities characterize asthma phenotypes? In search of proof |
| Q28247018 | Drug interactions with smoking |
| Q33742252 | Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal |
| Q39176351 | Effect of smoking status on the efficacy of the SMART regimen in high risk asthma |
| Q51528464 | Effect of smoking status on the efficacy of the SMART regimen in high risk asthma. |
| Q92546902 | Effects of short-term smoking on lung function and airway hyper-responsiveness in young patients with untreated intermittent adult-onset asthma: retrospective cross-sectional study at a primary-tertiary care hospital in Japan |
| Q33865223 | Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial |
| Q53625416 | Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. |
| Q38130512 | Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma |
| Q38537176 | Emerging corticosteroid agonists for the treatment of asthma |
| Q37343869 | Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen |
| Q37018920 | Eosinophilic airway inflammation in COPD |
| Q39411783 | Evaluation of asthma control and patient's perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China |
| Q37631543 | Factors affecting the development of adverse drug reactions (Review article) |
| Q42472228 | Genetic variation associates with susceptibility for cigarette smoke-induced neutrophilia in mice. |
| Q28761895 | Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease |
| Q34567189 | Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study |
| Q99634788 | Impact of Air Pollution on Asthma Outcomes |
| Q37754787 | Impact of comorbidities on asthma |
| Q38120057 | Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities |
| Q53173926 | Impact of smoking on asthma symptoms, healthcare resource use, and quality of life outcomes in adults with persistent asthma. |
| Q37268186 | Importance of evidence grading for guideline implementation: the example of asthma |
| Q34992972 | Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics |
| Q33329193 | Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis |
| Q37244948 | Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance. |
| Q38192641 | Integrating evidence for managing asthma in patients who smoke |
| Q33939572 | Long-term smoking increases the need for acute care among asthma patients: a case control study |
| Q37460865 | Management of asthma in adults |
| Q37027409 | Management of asthma in the elderly patient |
| Q36316775 | Management of severe asthma in children |
| Q43939902 | Managing asthma in primary care through imperative outcomes |
| Q93633740 | Minerva |
| Q34309275 | Nicotine stimulates nerve growth factor in lung fibroblasts through an NFκB-dependent mechanism. |
| Q40041782 | Novel anti-inflammatory treatments for asthma |
| Q38283811 | Novel biomarkers for asthma stratification and personalized therapy |
| Q36346376 | Overcoming gaps in the management of asthma in older patients: new insights |
| Q37756117 | Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches. |
| Q35532441 | Oxidants induce a corticosteroid-insensitive phosphorylation of histone 3 at serine 10 in monocytes |
| Q57491883 | Parental nicotine replacement therapy and offspring bronchitis/bronchiolitis and asthma - a nationwide population-based cohort study |
| Q38494475 | Peripheral blood dendritic cell subtypes are significantly elevated in subjects with asthma |
| Q36687379 | Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease |
| Q37578103 | Pharmacotherapy of asthma: regular treatment or on demand? |
| Q35113606 | Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues |
| Q33765604 | Prevalence trends in the characteristics of patients with allergic asthma in Beijing, 1994 to 2014 |
| Q33824058 | Proportional classifications of COPD phenotypes. |
| Q42115019 | Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice |
| Q36225742 | Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma |
| Q26797460 | Real-world research and its importance in respiratory medicine |
| Q34620187 | Recommendation for optimal management of severe refractory asthma |
| Q34240514 | Results from a community-based program evaluating the effect of changing smoking status on asthma symptom control |
| Q82013970 | Severe childhood asthma: a common international approach? |
| Q35855205 | Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma |
| Q37846701 | Smoking and nonsmoking asthma: differences in clinical outcome and pathogenesis |
| Q34949631 | Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study |
| Q38960423 | Step 4: stick or twist? A review of asthma therapy |
| Q35088162 | Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers |
| Q91950172 | Symptom control among asthmatics with a clinically significant smoking history: a cross-sectional study in Finland |
| Q46047575 | The effect of low-dose inhaled budesonide on PC20 AMP levels in patients with mild asthma: a 3-month follow-up study |
| Q35155828 | The glucocorticoid receptor: a revisited target for toxins |
| Q28076057 | The management of asthmatic smokers |
| Q38111795 | The misuse of asthma drugs |
| Q33785118 | Toll-like receptor-9 agonist inhibits airway inflammation, remodeling and hyperreactivity in mice exposed to chronic environmental tobacco smoke and allergen |
| Q37362600 | Treating patients with respiratory disease who smoke |
| Q36429918 | Update in asthma 2005. |
| Q38595241 | Use of asthma control indicators in measuring inhaled corticosteroid effectiveness in asthmatic smokers: a systematic review |
| Q93634324 | What's new this month in BMJ Journals |
| Q81193474 | [What is the therapeutic response to corticosteroid in smokers with asthma?] |
Search more.